Tactile Systems Technology Inc. | Micro-cap | Healthcare
$9.87
-2.57%
| Tactile Systems Stock Comparison:
Tactile Systems vs Abbott LaboratoriesTactile Systems vs Boston ScientificTactile Systems vs 908 DevicesTactile Systems vs MaxCyteTactile Systems vs PerspectiveTactile Systems vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 293.0M
Gross Profit 216.7M 73.96%
Operating Income 22.2M 7.57%
Net Income 17.0M 5.79%
EPS (Diluted) $0.70

Balance Sheet Metrics

Total Assets 297.9M
Total Liabilities 81.3M
Shareholders Equity 216.6M
Debt to Equity 0.38

Cash Flow Metrics

Operating Cash Flow 43.0M
Free Cash Flow 38.1M

Revenue & Profitability Trend

Tactile Systems Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue293.0M274.4M246.8M208.1M187.1M
Cost of Goods Sold76.3M79.3M70.8M59.8M54.3M
Gross Profit216.7M195.1M176.0M148.2M132.8M
Operating Expenses192.0M177.0M174.3M149.2M136.2M
Operating Income22.2M18.0M-12.8M-1.8M-3.6M
Pre-tax Income23.5M15.8M-15.5M-2.3M-2.3M
Income Tax6.5M-12.7M2.4M9.5M-1.6M
Net Income17.0M28.5M-17.9M-11.8M-620.0K
EPS (Diluted)$0.70$1.23-$0.89-$0.60-$0.03

Income Statement Trend

Tactile Systems Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets177.6M145.3M119.8M113.5M123.6M
Non-Current Assets120.4M136.1M135.2M130.7M50.5M
Total Assets297.9M281.4M255.0M244.3M174.1M
Liabilities
Current Liabilities40.7M41.1M64.3M34.5M26.7M
Non-Current Liabilities40.6M46.7M69.3M81.6M22.6M
Total Liabilities81.3M87.8M133.6M116.0M49.3M
Equity
Total Shareholders Equity216.6M193.6M121.4M128.2M124.8M

Balance Sheet Composition

Tactile Systems Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income17.0M28.5M-17.9M-11.8M-620.0K
Operating Cash Flow43.0M42.6M-5.9M1.4M-6.0M
Investing Activities
Capital Expenditures-2.4M-2.3M-1.8M-2.1M-2.1M
Investing Cash Flow-2.4M-2.3M-1.8M-81.9M20.4M
Financing Activities
Dividends Paid-----
Financing Cash Flow-6.5M4.2M-11.0M78.6M-1.9M
Free Cash Flow38.1M33.4M3.3M276.0K503.0K

Cash Flow Trend

Tactile Systems Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 15.41
Forward P/E 11.83
Price to Book 1.17
Price to Sales 0.81
PEG Ratio 11.83

Profitability Ratios

Profit Margin 5.52%
Operating Margin -7.41%
Return on Equity 8.12%
Return on Assets 4.66%

Financial Health

Current Ratio 4.52
Debt to Equity 21.23
Beta 0.95

Per Share Data

EPS (TTM) $0.66
Book Value per Share $8.72
Revenue per Share $12.27

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
tcmd236.4M15.411.178.12%5.52%21.23
Abbott Laboratories 231.9B17.314.7530.65%31.89%27.09
Boston Scientific 149.9B73.946.759.50%11.58%52.16
908 Devices 238.1M-3.121.49-48.15%-27.64%2.36
MaxCyte 230.7M-5.681.16-19.63%-110.92%9.44
Perspective 256.8M-3.340.90-32.92%0.00%1.34

Financial data is updated regularly. All figures are in the company's reporting currency.